Evaluation of the efficiency and safety of anaferon (pediatric formulation) in the treatment of chickenpox in children.
Addition of anaferon (pediatric formulation) to the therapy of chickenpox patients led to more rapid disappearance of the main symptoms and alleviated the course of the disease. The safety of the preparation is confirmed by the absence of undesirable events and stability of laboratory indexes against the background of therapy.